Design, Synthesis, and In Vitro Characterization of a Tryptamine-Based Visible-Light Photoswitchable 5-HT_2AR Ligand Showing Efficacy Preference for β-Arrestin over Mini-Gq.

Authors

Alexandra Sink, Eline Pottie, Samuel J Carter, Robert J Tombari, Verena Weber, Paolo Carloni, Giulia Rossetti, David E Olson, Christophe P Stove, Michael Decker

Published in

Journal of medicinal chemistry. Jun 18, 2025. Epub Jun 18, 2025.

Abstract

The serotonin 2A receptor (5-HT_2AR) modulates various neurotransmitter systems and is implicated in psychiatric disorders, including depression and schizophrenia. Despite progress, the detailed mechanisms of signaling at the 5-HT_2AR and its therapeutic implications remain unclear, warranting further exploration. Overcoming the limitations of conventional pharmacology, photopharmacology addresses issues such as spatial selectivity and spatiotemporal resolution by incorporating light as an additional external control element. To study the roles of G protein- and β-arrestin2-dependent signaling pathways independently, we designed a photoswitchable, pathway-selective 5-HT_2AR ligand. In radioligand binding studies, the cis-photoisomer has a greater affinity than the trans-isomer at the 5-HT_2AR and binds at nanomolar concentrations. In two highly analogous functional assays, the photoswitchable ligand showed a preference for β-arrestin2 recruitment over mini-Gα_q recruitment relative to LSD, providing a compelling tool for investigating the role of β-arrestin2 recruitment in 5-HT_2AR signaling and elucidating its potential role in psychedelic effects.

PMID:
40532050
Bibliographic data and abstract were imported from PubMed on 19 Jun 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.